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  42 
Abstract 43 
 44 
Background: Rotator cuff tears are the commonest tendon injury in the adult 45 
population, resulting in substantial morbidity. The optimum management for these 46 
patients is not known.  47 
 48 
Purpose: To assess the overall treatment response to all interventions in full-49 
thickness rotator cuff tears in patients enrolled in randomised clinical trials. 50 
 51 
Study Design: Systematic review and meta-analysis. 52 
 53 
Methods: Randomised controlled trials (RCTs) were identified from a systematic 54 
search of Medline, Embase and CINAHL databases. Patients aged 18 or over with 55 
full-thickness rotator cuff tear. The primary outcome measure was change of 56 
Constant shoulder score from baseline at 52 weeks. A meta-analysis to assess 57 
treatment response was calculated using the standardised mean change in scores.  58 
 59 
Results: We included 57 RCTs. The pooled standardised mean change, compared to 60 
baseline was: 1.42 (95% CI 0.80-2.04) at 3 months, 2.73 (95% CI 1.06-4.40) at 6 61 
months and 3.18 (95% CI 1.64-4.71) at 12 months. Graphical plots of treatment 62 
response demonstrate a sustained improvement in outcomes in both non-operative 63 
trial arms and all operative sub-group arms.  64 
 65 
Conclusions: Patients with full-thickness rotator cuff tears demonstrated a consistent 66 
pattern of improvement in Constant score with both conservative and operative care. 67 
The natural history of patients with rotator cuff tears included in RCTs is to improve 68 
over time, whether treated operatively or non-operatively.  69 
 70 
What is known about the subject: Rotator cuff tears represent the commonest tendon 71 
injury in the adult population, however the optimum management of these patients is 72 
not known. In other chronic musculoskeletal conditions, it has been shown that there 73 
is improvement in clinical outcome measures with all treatments over time. However, 74 
it is not known if this is also true for rotator cuff tears.  75 
 76 
What this study adds to existing knowledge: This review found there is consistent 77 
improvement in Constant score, irrespective of intervention given whether it is 78 
operative, or non-operative treatments. Patient outcomes at 12 months are highly 79 
predictive of outcomes at 24 months, suggesting that 12-month should be used as a 80 
primary outcome time point for future randomised controlled trials in full-thickness 81 
rotator cuff tears.   82 
MAIN TEXT 83 
Introduction 84 
 85 
Rotator cuff tears are the commonest tendon injury in the adult population, affecting 86 
approximately 30% of the population above the age of 60 82. The prevalence 87 
increases with age. Risk factors for development include male gender, employment 88 
consisting of manual labour and previous trauma 96. Whilst many tears are 89 
asymptomatic, up to 35% of patients will then progress to develop pain and inability 90 
to perform activities of daily living 70,95. For patients with full-thickness rotator cuff 91 
tears there is debate about the optimum management, including the use of different 92 
operative techniques, operative adjuncts, and non-operative management 25,56. 93 
Nevertheless, there has been a trend to provide more surgical treatments for these 94 
injuries. The number of rotator cuff repairs performed in the UK increased by 238% 95 
over 14 years to 2009 27. 96 
 97 
Over recent years there has been a substantial growth in the number of randomised 98 
controlled trials and systematic reviews of shoulder treatments 38,40,41,66. However, 99 
most studies show, at best, a modest additional improvement in patient reported 100 
outcomes over time, with no clear superiority of one treatment modality over the 101 
other 38,40,41,66.  102 
 103 
In other chronic, painful conditions, it has been noted that outcomes improve over 104 
time in patients in randomised trials, regardless of their treatment 3,4,90. This may be 105 
due to the natural history of chronic musculoskeletal conditions, regression to the 106 
mean or other unrecognised mechanisms. As a result, it presents a challenge for the 107 
interpretation of outcomes in studies of patients with rotator cuff tears. Randomised 108 
trials are a good source of information on the natural history of a condition because 109 
they have well defined entry criteria, are prospective by definition, and typically have 110 
well defined follow-up time points. In addition, the natural history of patients with 111 
rotator cuff pathologies in randomised controlled trials needs to be better understood 112 
to improve the planning and conduct of further trials in this area.  113 
 114 
 115 
Aims: To assess the outcomes and trajectories over time amongst patients with full-116 
thickness rotator cuff tears in randomised clinical trials.   117 
Methods 118 
 119 
This study was reported in accordance with the PRISMA statement for reporting 120 
systematic reviews. The systematic review protocol was pre-defined and can be 121 
found at http://www.crd.york.ac.uk/PROSPERO (CRD42016047715).  122 
 123 
Inclusion Criteria 124 
 125 
Inclusion criteria were: (i) full text, randomised controlled trials in English language, 126 
(ii) any humans of any age with isolated full thickness rotator cuff tears, (iii) studies 127 
comparing both operative and non-operative interventions and (iv) reporting clinical 128 
outcome measures chosen for this review were included.  129 
 130 
Exclusion Criteria 131 
 132 
Exclusion criteria were: (i) non-randomised studies, (ii) studies reporting 133 
biomechanical and radiological outcomes, (iii) studies not reporting clinical outcomes 134 
selected for this review and (iv) abstract publication only.  135 
 136 
Studies including patients with partial-thickness tears or examining treatments for 137 
shoulder disorders other than full-thickness tears were also excluded. 138 
 139 
Up to three attempts were made to contact the corresponding author for additional 140 
information if; (i) further information was required about study design to confirm 141 
inclusion, (ii) there were missing data for unreported or partially unreported outcomes 142 
or (iii) outcomes were for the full-thickness sub-population where the study 143 
population was mixed (full thickness and other pathologies). 144 
 145 
Outcome measures 146 
 147 
The primary outcome measure was the Constant shoulder score 20 at 52 weeks. The 148 
Constant score is the most widely used shoulder evaluation score in Europe 51 and 149 
has been described as the most efficient outcome measure for patients with rotator 150 
cuff tears 61. It is a composite core measuring a combination of physical examination 151 
and subjective assessments from the patient.  152 
 153 
The secondary outcome measures included: (i) the American Shoulder and Elbow 154 
Score (ASES) 83 at all time points, (ii) the University California-Los Angeles (UCLA) 2 155 
score at all time points, (iii) the Disabilities of the Arm, Shoulder and Hand (DASH) 39 156 
and (iv) Constant score (including modifications of the Constant score) 20 at all time 157 
points.  158 
 159 
Search Strategy and quality assessment  160 
 161 
We searched Medline, Embase, The Cochrane central register of controlled trials 162 
and CINAHL databases from inception to 14th September 2016 and imported 163 
citations into EndNote X7 (New York, USA) reference management software. A full 164 
search strategy can be found in the supplementary material. Following removal of 165 
duplicates, citations were screened using title and abstract with the inclusion criteria 166 
described above applied. To reduce the risk of publication bias, if multiple studies 167 
reported the same, or an overlapping population, only the study with the longest 168 
follow up was included. For those studies that potentially met eligibility criteria, full 169 
texts were obtained. Two authors (CK & IA) independently assessed each paper, 170 
with any discrepancies being resolved with discussion with the senior authors (NS & 171 
AM).  172 
 173 
We did a qualitative risk of bias assessment using Cochrane guidelines 37. Where the 174 
main paper did not include sufficient information to complete risk of bias assessment 175 
any published protocols were also examined.  176 
 177 
Statistical analysis 178 
 179 
We extracted outcome data from each study according to follow up time period. As 180 
there was often a wide heterogeneity in follow up time points, the exact time point 181 
was recorded, even if different for study arms. As performed in a similar meta-182 
analysis by Artus et al. 3, we developed a data analysis plan, including a descriptive 183 
analysis, assessment of the variation of size of response and finally the overall 184 
pattern of response prior to data extraction.  185 
 186 
Extracting data 187 
 188 
We extracted the number of patients in each arm, the intervention type for each arm, 189 
which was defined as repair, acromioplasty alone or conservative. In addition, the 190 
mean and standard deviation (SD) of Constant score (standard and modified), 191 
gender, dominant hand and the time point assessed were extracted for each study. If 192 
a study did not report one of these statistics, then estimates of missing values were 193 
calculated from other reported values, such as the test statistic or p-value using 194 
standard methods as described in the Cochrane Handbook 34. Where data in studies 195 
was not represented in numerical format, data were extracted from graphs by two 196 
authors (CK & IA) to improve accuracy of data.  197 
 198 
Assessing the general response of treatment 199 
 200 
Outcome scores were graphically plotted against time using Microsoft Excel 201 
(Microsoft Excel for Mac 2011, Washington, USA) to describe change from baseline 202 
to all follow up points reported in all treatment arms from included studies. Data were 203 
explored visually for a descriptive analysis of response. As a visual response trend 204 
was required, studies using modified versions of Constant score were included.  205 
 206 
Assessing variation of size of response 207 
 208 
To determine variation in size of response we analysed the change in outcome score 209 
by calculating the bias-corrected standardised mean change (SMC) at three, six, 12 210 
and 24 months). This technique is used frequently when studies report efficacy in 211 
terms of a continuous measurement. For example, it could be used when comparing 212 
the outcome of a new analgesic drug using visual analogue pain scales as an 213 
outcome, comparing intervention and placebo. The SMC could be interpreted as the 214 
‘standardised’ measure of outcome, where (assuming high scores denote more 215 
severe pain) if there were no difference between the interventions, the SMC would 216 
be zero, whilst a negative SMC would represent a reduction in pain. The SMC score 217 
is calculated by subtracting the follow up mean score in chosen outcome measure 218 
from the baseline mean score. This is then divided by its pooled SD, multiplied by a 219 
bias correction factor based on the group size 71. If the pooled SD was not reported, 220 
the baseline SD was used, or the SD at follow up. Estimates of the variance of the 221 
SMC were also calculated 72 and used to construct 95% confidence intervals. To 222 
allow for the repeated measures design, the within-group correlation was set at 0.5 223 
for all studies 17.  224 
 225 
Summarising the overall response to treatment 226 
 227 
As the SMC standardises the measurement of change over time, studies using 228 
slightly different scales can be pooled together for comparison. As such, studies 229 
using modified or adjusted Constant scores were combined alongside those that 230 
reported unmodified scales. As for similar meta-analyses 3, one arm was then 231 
randomly selected per trial. This was because changes in outcome over time were of 232 
interest, rather than between arms comparison (e.g. to demonstrate superiority of 233 
one type of intervention). Intervention arms from each study are likely to be further 234 
correlated since participants recruited to each trial are likely to have similar 235 
characteristics and therefore have a similar response to treatment, which means that 236 
observations from different study arms would not be independent. Furthermore, the 237 
objective of this review was to describe the effect of treatments and not to estimate 238 
effect sizes between intervention groups. 239 
 240 
We calculated a combined pooled estimate of SMC for each time point using a 241 
random effects model. Studies were subcategorised according to treatment given to: 242 
(i) where primary repair was performed (ii) where acromioplasty was performed only 243 
iii) conservative (non-operative) treatment. If patients had a primary repair and 244 
another treatment adjunct was applied (such as the application of platelet rich protein 245 
or acromioplasty) the study arm was allocated to repair group.  We did a simple 246 
correlation analysis (using Pearson’s correlation coefficient) on the SMCs between 247 
each time point to assess the relationship between each subsequent time point.  248 
 249 
Analyses were conducted in R (Vienna, Austria) 80 and using the metafor package 92. 250 
  251 
Results 252 
 253 
A total of 1033 citations were received from our search strategy. After removal of 254 
duplicates and screening of studies by title and abstract, 100 full text papers were 255 
retrieved. Out of these, 57 studies met our inclusion criteria from which 43 studies 256 
used the Constant score as an outcome measure (Figure 1). Of the 57 studies 257 
selected, 14 study authors were contacted for further information, however no 258 
responses were received.  259 
Figure 1: Flow diagram detailing inclusion of studies into the review.  260 
 261 
Description of studies included  262 
 263 
With respect to studies reporting the Constant score; there were 39 studies with 73 264 
arms that described treatment response for operative interventions of which eight 265 
studies with eight arms had repair and acromioplasty performed; two studies with two 266 
arms for acromioplasty only; five studies with seven arms were described for non-267 
operative interventions. 26 studies with 53 arms reported the ASES score; 20 studies 268 
with 40 treatment arms reported the UCLA score. The DASH was the least frequently 269 
reported score, with seven studies reporting 14 different treatment arms. A 270 
description of included studies is available in Table 1.  271 
 272 
Description of patient population included 273 
 274 
We included data from 4542 participants in this review, with study populations 275 
ranging from a minimum of 20 to 248 patients. Within the included studies, eight did 276 
not report gender. Of those that did report gender of patients included, 48% of 277 
participants were male. Four studies out of 57 did not report age; in those that did, 278 
the median of the mean reported age of participants was 59.0 (IQR 5.3). Of those 279 
studies included, 27 did not report dominant hand of included patients. From those 280 
studies reporting, 71% of participants had a full-thickness tear of their dominant side.   281 
 282 
Risk of bias assessment 283 
 284 
Studies included in this review had a low risk of bias for all domains apart from 285 
blinding of participants and personal (performance bias); 42% (24/57) of studies had 286 
a low risk of performance bias: 47% (27/57) of studies had an unclear risk of bias 287 
(Figure 2). 288 
Figure 2: Summary Table of Risk of Bias Assessment for Studies Included  289 
 290 
The general response to treatment 291 
 
Figure 2: Summary Table of Risk of Bias Assessment for Studies Included  
 
  
 
 
 292 
There was an overall improvement in all arms from baseline for studies reporting 293 
Constant score (Figure 3). When exploring differences between operative and non-294 
operative arms, this effect was sustained, with all study arms showing positive 295 
change. Treatment response in all outcome measures (ASES, UCLA and DASH) 296 
showed an improvement in functional outcomes regardless of treatment intervention 297 
applied (Figure 4). Studies that followed up patients at multiple time points indicate 298 
an improvement in outcome in the first 12 months, following which the rate of 299 
improvement stabilised. This pattern was consistent irrespective of treatment type 300 
given (primary repair, acromioplasty only, or non-operative intervention).  301 
Figure 3: Change in Constant score for all operative and non-operative interventions 302 
over time (includes modified Constant score) 303 
 304 
 305 
  306 
 307 
Figure 4: Change in ASES, UCLA and DASH score over time for all interventions 308 
 309 
 310 
  311 
 Summary of responses to treatments 312 
 313 
A forest plot describing the pooled SMC from baseline for all sampled treatment arms 314 
was produced for the Constant Score (Figure 5). This showed a large pooled 315 
treatment response at 3 months (1.42 [95% CI 0.80-2.04]) and at 6 months (2.73 316 
[95% CI 1.06-4.40]). The largest change was seen at 12 months (3.18 [95% CI 1.64-317 
4.71], which then reduced slightly at 24 months (2.98 [95% CI 1.40-4.55]).  318 
Figure 5: SMC for Constant score for one arm randomly selected from each trial arm 319 
at 3, 6, 12 and 24 months.  320 
 321 
 322 
In the sub-group analysis, the greatest effects were seen in patients undergoing 323 
rotator cuff repair, although a meta-analysis of papers directly comparing the two was 324 
not performed and therefore this should not be taken as direct evidence of benefit for 325 
repair. Trends in the effects followed the same pattern as observed in the main 326 
analysis, with the largest effects observed at 12 months with a SMC of 3.65 (95% CI 327 
1.74-5.56) for patients undergoing repair compared to 1.78 (95% CI 1.10-2.46) for 328 
conservative and 0.27 (95% CI 0.01-0.53) for acromioplasty patients.  329 
 330 
There was strong correlation in SMCs for each time point, which increased as the 331 
studies progressed. The Pearson’s correlation coefficients were 0.816 (n=11, 95% CI 332 
0.424 to 0.951) between 3 months and 6 months, 0.987 (n=13, 95% CI 0.957 to 333 
0.996) between 6 months and 12 months and 0.999 (n=9, 95% CI 0.996 to 1.00) 334 
between 12 months and 24 months. 335 
  336 
Discussion 337 
 338 
We aimed to collate the evidence on the short-term natural history of patients with 339 
symptomatic full-thickness rotator cuff tears, regardless of the treatment they 340 
received. The studies included in this review examined a wide variety of treatment 341 
modalities, including a variety of operative techniques as well as non-operative 342 
interventions. This review found that treatment response follows a similar pattern of 343 
rapid improvement in the first 12 months after an intervention, after which the 344 
recovery plateaus. This pattern was found in all treatment arms irrespective of 345 
intervention applied, including either surgical or non-surgical care.  346 
 347 
Whilst assessing the natural history of a condition using randomised trial data alone 348 
may seem counter-intuitive, there are a number of good reasons for doing so. 349 
Randomised trials typically have well organised follow-up arrangements at fixed time 350 
periods from randomisation, which are usually pre-defined. By definition, they are 351 
prospective studies in well-defined populations. A well-constructed cohort study can 352 
achieve all of these things but this is harder to detect and assess when reviewing a 353 
paper, and many cohort studies suffer from being conducted with cross-sectional 354 
sampling, meaning that follow-up times vary considerably from the intervention. This 355 
may be valuable in a long-term follow up study, but the purpose of this study was to 356 
examine short to medium-term outcomes (that is, in the first few months and years 357 
after the intervention) and as such, randomised trials provide a wealth of prospective 358 
data with fixed time points for follow up. 359 
 360 
In determining an explanation for the patterns that were observed, consideration 361 
must be given to the natural history of rotator cuff tears. Previously conducted 362 
systematic reviews have commented on the scarcity of studies investigating the topic 363 
26. A cohort study by Safran and colleagues assessing the natural history in 364 
symptomatic, full-thickness rotator cuff tears who were treated non-operatively found 365 
that patients often had progression in tear size which was linked to a deterioration in 366 
pain 86. This is different to our findings, where we found non-operatively treated 367 
patients improve in outcome measures. In the above study, it is not explained why 368 
their cohort was treated non-operatively, as perhaps these patients may have been 369 
unsuitable for operative intervention. On comparison, in half of the studies included in 370 
this review with a non-operative arm, participants would have been suitable for an 371 
operative intervention. In addition, people included in studies with only non-operative 372 
arms may not have had significant disability to seek operative intervention. As such 373 
this may represent two different sub-sections of the population.  374 
 375 
Moosmayer found that patients with asymptomatic rotator cuff tears often progressed 376 
to become symptomatic, representing a structural deterioration of the rotator cuff 70. 377 
However, this patient cohort differs from those entered into randomised controlled 378 
trials, as asymptomatic patients are unlikely to actively seek healthcare. In contrast, 379 
patients seeking surgical treatment are likely to represent a sub-section of the 380 
population with the worst symptoms, leading to lower baseline outcome scores. As 381 
such, these patients also represent those who have the potential for larger reductions 382 
in symptoms and therefore the greatest treatment response.  383 
 384 
The phenomenon of regression to the mean is a ubiquitous statistical occurrence in 385 
repeated data. This suggests that if a variable is extreme on its first measurement, it 386 
will tend to be closer to the population mean on subsequent measurements 73. In 387 
other words, if a patient’s pain varies, they will typically see a specialist and be 388 
entered for treatment (or into a study) when the pain is at its peak, and in future 389 
measurements it will be reduced as the pain then falls from that previous peak. As 390 
such, patients with worse baseline outcome measures represent those with greater 391 
potential to improve due to regression to the mean. Equally, it may be that patients 392 
who present with pain and symptoms will recover with time and patient care, as 393 
implied by these studies where there is a large effect and regression to the mean 394 
may seem to be unlikely. In reality, it is difficult to separate the effects of regression 395 
to the mean from the true natural history of full-thickness tears.  396 
 397 
Thought must also be given to non-specific factors for change in outcomes. Indeed, 398 
there is evidence to suggest participation in randomised controlled trials may itself 399 
confer benefit to patients 13. This effect is particularly seen in situations where 400 
effective treatments are included in the trial protocol 13, such as for many studies 401 
included in this review. Other factors, such as trust in health care professional 402 
delivering treatment 10 and the manner in which patients expectations for treatment 403 
response is enhanced by positive information 11 all significantly contribute to the 404 
improvement of health outcomes. In addition, attributes from the patient including 405 
their expectation, emotions and psychological conditioning have been found to be of 406 
positive influence 52,79. Perhaps the best recognised is the role of the placebo in 407 
influencing outcomes. Whilst its influence within drug trials is well established, there 408 
is evidence for its use as an effective treatment in other chronic musculoskeletal 409 
conditions 97. Furthermore, the placebo can be augmented with previously mentioned 410 
factors such as clinician warmth 45. Again it is difficult to estimate the effect of these 411 
factors into the trials included in this study.  412 
 413 
One other consideration is the timing of outcomes in randomised studies. It is 414 
common for reviewers to insist on 24-month outcomes, however we found that they 415 
add little value beyond 12 months. After 12 months in all treatment arms, the 416 
improvement stabilised, and correlations in scores at different time points were very 417 
high. In other words, once the 12-month outcomes were known then the 24-month 418 
outcomes were highly predictable. We recommend a 12-month primary outcome 419 
based on our findings. This has important implications in the delivery of randomised 420 
trials, which are often expensive and time consuming, and reporting at 12 rather then 421 
24 months would save substantial cost as well as time in producing an answer that 422 
can be delivered to improved clinical care for patients, whereas waiting for a 24 423 
month follow-up adds little. This is not to say that later follow-up (say, five or ten 424 
year) does not add different or valuable information, but in terms of short to medium-425 
term outcomes, a primary outcome at 12 months can be recommended based on our 426 
findings. 427 
 428 
Surgical treatments may be effective, although their true effect over non-operative 429 
treatment is likely to be much less than the effect that seen in uncontrolled case-430 
series. Our data show that such an improvement may also be seen with conservative 431 
treatments. The overall effect of surgery can only be assessed by comparing surgery 432 
to conservative treatment, and consideration should also be given sham or placebo 433 
controlled trials of surgery 31,94. When assessing the results of surgical procedures, 434 
and surgeons should be aware of the natural history of symptomatic cuff tears in the 435 
short term to improve substantially with conservative care alone when they assess 436 
the result of other treatments or procedures. 437 
 438 
Strengths and Limitations 439 
 440 
This study was conducted and reported in accordance with the PRISMA guidelines 441 
67. It was conducted with a pre-defined and published study protocol.  442 
 443 
We used the Constant score as its primary outcome measure. It is the most widely 444 
used assessment tool 51 and was the most frequently outcome measure in studies 445 
included in this review thus giving the greatest volume of data to pool. Other 446 
measures used in this review including ASES, UCLA score and the DASH score 447 
were next commonly reported and thus represented an appropriate secondary 448 
outcome measures. A small number of trials used other measures such as change in 449 
visual analogue score, or purely radiological outcome measures, which were 450 
therefore not included. As these were so infrequently reported and varied in their 451 
definitions, any meaningful pooling of this data would not have been possible.  452 
 453 
Only trials with fully published outcome measures were included. Thus, there is a risk 454 
of publication bias from studies with incomplete outcome data, which were excluded 455 
from the study analysis. In line with Cochrane guidelines, authors of the papers were 456 
contacted with reasonable efforts in order to minimise this. A further limitation is that 457 
only English language studies were included. However, this results in only two 458 
studies being excluded and those that were included were from a wide distribution 459 
geographically. The large number of included studies showing consistent results 460 
suggests is unlikely that our conclusions would be changed if any other such studies 461 
had been included. 462 
 463 
This study has not been designed as a meta-analysis to directly compare rotator cuff 464 
repair, acromioplasty or physiotherapy, and rather is a description of the natural 465 
history of each treatment. Conclusions on the relative merits of the treatments should 466 
not be directly inferred from these findings. Different studies are included which may 467 
have had different populations in them. An example of this is the apparent worse 468 
performance of acromioplasty relative to repair or conservative care. Whilst the study 469 
did adjust for baseline scores, the different studies are not necessarily the same 470 
population of patients or types of tear, so care should be taken in over-interpreting 471 
our findings. However, it makes an important statement about the likely outcome of 472 
patients with symptomatic cuff tears over time, and this needs to be considered when 473 
interventions such as surgery are being considered, or when other treatments are 474 
being evaluated. 475 
 476 
We did not assess the long-term outcomes of these patients. Certainly, it is 477 
established that massive rotator cuff tears can lead to the development of rotator cuff 478 
arthropathy 24. This may then result in a deterioration of outcomes and there is 479 
evidence to suggest early repair of rotator cuff tears can prevent progression into 480 
rotator cuff arthropathy 19,74. Unfortunately long term outcomes were beyond the 481 
scope of this review as it was based on trial data, which typically does not extend 482 
long enough to assess long-term outcomes.  483 
Conclusions 484 
 485 
We have shown that patients with symptomatic full-thickness rotator cuff tears 486 
demonstrate a consistent and considerable response to treatment, even with 487 
conservative management. The largest improvement occurs in the first 12 months, 488 
after which the response stabilises. When assessing the treatment effect of invasive 489 
surgery, consideration must be given to the natural history of patients with rotator cuff 490 
tears to improve over time with non-operative care as well. 491 
 492 
 493 
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Table 1: Study Characteristics 
 
Author Year 
published 
 
Comparison Participants 
(n) 
Male 
(n) 
Female 
(n) 
Age Dominant 
side (n) 
Non dominant 
side (n) 
Abrams et 
al. 1 
2014 Repair vs. Repair & 
Acromioplasty 
114 64 
(56.1%) 
50 
(43.9%) 
58.8   
Aydin et al. 
5  
2010 Single vs. Double Row Repair 68   58.0   
Barber et al. 
91 
2016 Single vs. Double Row Repair 40 24 
(60.0%) 
16 
(40.0%) 
56.0 33 7 
Barber et al. 
6 
2012 Repair vs. Repair & Human 
Dermal Matrix  
42 31 
(73.8%) 
11 
(26.2%) 
56.0   
Berth et al. 7 2010 Partial Repair vs. Debridement 
& Acromioplasty 
42 31 
(73.8%) 
11 
(26.2%) 
63.4 29 13 
Bidwai et al. 
8 
2016 Mini-Open Repair vs. 
Acromioplasty 
33 26 
(78.8%) 
7 
(21.1%) 
67.7   
Bigoni et al. 
9 
2009 Side-to-Side Repair vs. 
Tendon–to–Bone Fixation 
50   59.0   
Boehm et al. 
12 
2005 Mason-Allen Suture vs. 
Kessler Suture 
100 68 
(68.0%) 
32 
(32.0%) 
56.5   
Bryant et al. 
14 
2016 Repair & Porcine Small 
Intestine Mucosa vs. Repair 
62 51 
(81.3%) 
11 
(17.7%) 
56.6   
Burks et al. 
15 
2009 Single vs. Double Row Repair 40   56.5   
Carbonel et 
al. 16 
2012 Single vs. Double Row Repair 160 68 
(43.5%) 
92 
(57.5%) 
55.5   
Castricini et 2011 Repair & Platelet Rich Plasma 88 40 48 55.3   
al. 18 vs. Repair (45.5%) (55.5%) 
Cuff et al. 21 2012 Early Physiotherapy vs. Late 
Physiotherapy 
68 38 
(55.9%) 
30 
(44.1%) 
63.2   
Dezaly et al. 
22 
2011 Repair & Acromioplasty vs. 
Acromioplasty 
127 58 
(45.7%) 
69 
(54.3%) 
67.8   
Duzgun et 
al. 23 
2011 Early Rehabilitation vs. Late 
Rehabilitation 
29 3 
(10.3%) 
26 
(89.7%) 
56.3   
Flurin et al. 
28 
2013 Repair vs. Repair & 
Acromioplasty 
154 60 
(39.0%) 
94 
(61.0%) 
74.3   
Franceschi 
et al. 29 
2007 Single vs. Double Row Repair 60      
Gartsman et 
al. 30 
2004 Repair & Acromioplasty vs. 
Repair 
93 42 
(45.2%) 
51 
(55.8%) 
59.7   
Gialanella et 
al. 32 
2011 Steroid Injection vs. Steroid 
injection vs. No Treatment 
(Control) 
60 5 
(8.3%) 
55 
(91.7%) 
 
78.7   
Grasso et 
al. 33 
2009 Single vs. Double Row Repair 80 34 
(42.5%) 
46 
(57.5%) 
56.8 56 24 
Greiner et 
al. 35 
2015 Lateralised Reverse Shoulder 
Arthroplasty vs. Reverse 
Shoulder Arthroplasty 
34 12 
(35.3%) 
 
22 
(64.7%) 
75.4   
Gumina et 
al. 36 
2012 Repair & Platelet/Leucocyte 
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(51.3%) 
39 
(48.8%) 
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(48.5%) 
53 
(51.5%) 
68.0 75 28 
Jo et al. 43 2013 Repair & Platelet Rich Plasma 48 24 24 63.1 42 6 
vs. Repair (50.0%) (50.0%) 
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124      
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105 44 
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55 
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100      
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38 24 
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(54.7%) 
24 
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45 
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(60.0%) 
44 
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73 41 
(51.2%) 
32 
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63 42 
(66.7%) 
21 
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56.6 55 8 
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(70.9%) 
30 
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2016 Repair & Platelet Rich Plasma 
vs. Repair 
102 74 
(72.5%) 
28 
(27.5%) 
54.0 65 37 
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2013 Repair & Platelet Rich Plasma 
vs. Repair 
53 21 
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32 
(43.8%) 
60.0 41 12 
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2012 Repair & Platelet Rich Plasma 
vs. Repair 
79 44 
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35 
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78 55 
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23 
(29.5%) 
61.5 50 28 
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Repair 
120 67 
(55.8%) 
53 
(44.2%) 
56.8 87 33 
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95 57 
(60.0%) 
38 
(40.0%) 
57.6 72 23 
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95 
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108 55 
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53 
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20 10 
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10 
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